Convalescent plasma trial shows no benefit.
作者信息
Brown Matthew
机构信息
Sinai Immunology Review Project, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
Nat Rev Immunol. 2020 Nov;20(11):649. doi: 10.1038/s41577-020-00461-3.
Abstract
摘要
相似文献
1
Convalescent plasma trial shows no benefit.康复期血浆试验未显示出益处。
Nat Rev Immunol. 2020 Nov;20(11):649. doi: 10.1038/s41577-020-00461-3.
2
Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak.2014 - 2015年埃博拉疫情期间在几内亚进行的评估恢复期血浆治疗埃博拉病毒病的埃博拉治疗试验中的设计与分析考量
Clin Trials. 2016 Feb;13(1):13-21. doi: 10.1177/1740774515621056. Epub 2016 Jan 14.
3
The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2.新冠病毒高滴度康复期血浆的证据
SN Compr Clin Med. 2021;3(3):790-792. doi: 10.1007/s42399-021-00827-1. Epub 2021 Feb 18.
4
Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia.康复期血浆可降低中度新冠肺炎肺炎患者的死亡率并缩短住院时间。
Metabolites. 2021 Nov 5;11(11):761. doi: 10.3390/metabo11110761.
5
Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.恢复期血浆治疗 2019 冠状病毒病（COVID-19）：临床试验设计的考虑因素。
Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.
6
A 63-Year-Old Woman with SARS-CoV-2 Infection, Who Developed Severe COVID-19 Pneumonia and Was Supported with Convalescent Plasma Therapy.一名63岁感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的女性，她发展为重症冠状病毒病2019（COVID-19）肺炎并接受了恢复期血浆治疗。
Am J Case Rep. 2020 Sep 29;21:e927662. doi: 10.12659/AJCR.927662.
7
Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies.病原体灭活的埃博拉病毒康复期血浆：迈向制造标准化和质量控制的第一步，包括评估埃博拉特异性中和抗体。
Vox Sang. 2016 May;110(4):329-35. doi: 10.1111/vox.12376. Epub 2016 Jan 14.
引用本文的文献
1
Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach.天然产物治疗 COVID-19：一种基于特定人群的调查导向方法。
Molecules. 2021 Feb 23;26(4):1191. doi: 10.3390/molecules26041191.
本文引用的文献
1
A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits.学术实验室生产新型冠状病毒实时荧光定量聚合酶链反应检测试剂盒的蓝图。
medRxiv. 2020 Sep 1:2020.07.29.20163949. doi: 10.1101/2020.07.29.20163949.
Zotero 插件